TY - JOUR
T1 - Strategies to Reduce Hospital Readmissions
AU - Chirapongsathorn, Sakkarin
AU - Talwalkar, Jayant A.
AU - Kamath, Patrick Sequeira
PY - 2016/5/1
Y1 - 2016/5/1
N2 - After the Patient Protection and Affordable Care Act or Obamacare was signed into law in 2010, the problem of readmission has taken on a new sense of urgency. Hospitals with excess readmissions receive reduced reimbursement because readmission is considered to represent a poor quality measure in the healthcare delivery system. Cirrhosis places a major burden on the healthcare economy. Patients with cirrhosis frequently require hospitalization, and annual admission rates have doubled within 10 years. The costs of hospitalization associated with cirrhosis have also markedly increased. Readmissions create negative consequences for the patient and the family. Several strategies have been proposed to reduce the number of readmissions, but the efficacy of these strategies is questionable. Although the Model for End-Stage of Liver Disease (MELD) score can be a tool for risk stratification, many other factors are also independent risks for readmission. Studies aimed at the reduction of readmission in patients with cirrhosis are very limited, and much research is required before specific recommendations can be made to reduce readmissions.
AB - After the Patient Protection and Affordable Care Act or Obamacare was signed into law in 2010, the problem of readmission has taken on a new sense of urgency. Hospitals with excess readmissions receive reduced reimbursement because readmission is considered to represent a poor quality measure in the healthcare delivery system. Cirrhosis places a major burden on the healthcare economy. Patients with cirrhosis frequently require hospitalization, and annual admission rates have doubled within 10 years. The costs of hospitalization associated with cirrhosis have also markedly increased. Readmissions create negative consequences for the patient and the family. Several strategies have been proposed to reduce the number of readmissions, but the efficacy of these strategies is questionable. Although the Model for End-Stage of Liver Disease (MELD) score can be a tool for risk stratification, many other factors are also independent risks for readmission. Studies aimed at the reduction of readmission in patients with cirrhosis are very limited, and much research is required before specific recommendations can be made to reduce readmissions.
KW - cirrhosis
KW - complications of cirrhosis
KW - healthcare delivery
KW - MELD score
KW - readmission
UR - http://www.scopus.com/inward/record.url?scp=84967110072&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84967110072&partnerID=8YFLogxK
U2 - 10.1055/s-0036-1583196
DO - 10.1055/s-0036-1583196
M3 - Article
C2 - 27172358
AN - SCOPUS:84967110072
SN - 0272-8087
VL - 36
SP - 161
EP - 166
JO - Seminars in Liver Disease
JF - Seminars in Liver Disease
IS - 2
ER -